DE69628672D1 - Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit - Google Patents

Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit

Info

Publication number
DE69628672D1
DE69628672D1 DE69628672T DE69628672T DE69628672D1 DE 69628672 D1 DE69628672 D1 DE 69628672D1 DE 69628672 T DE69628672 T DE 69628672T DE 69628672 T DE69628672 T DE 69628672T DE 69628672 D1 DE69628672 D1 DE 69628672D1
Authority
DE
Germany
Prior art keywords
risperidon
transdermal administration
controlled speed
controlled
speed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69628672T
Other languages
English (en)
Other versions
DE69628672T2 (de
Inventor
Louis Mesens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE69628672D1 publication Critical patent/DE69628672D1/de
Application granted granted Critical
Publication of DE69628672T2 publication Critical patent/DE69628672T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69628672T 1995-04-06 1996-03-29 Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit Expired - Lifetime DE69628672T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200867 1995-04-06
EP95200867 1995-04-06
PCT/EP1996/001421 WO1996031201A1 (en) 1995-04-06 1996-03-29 Rate-controlled transdermal administration of risperidone

Publications (2)

Publication Number Publication Date
DE69628672D1 true DE69628672D1 (de) 2003-07-17
DE69628672T2 DE69628672T2 (de) 2004-04-29

Family

ID=8220172

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69628672T Expired - Lifetime DE69628672T2 (de) 1995-04-06 1996-03-29 Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit

Country Status (17)

Country Link
EP (1) EP0879051B9 (de)
JP (1) JPH11503138A (de)
KR (1) KR100437672B1 (de)
AR (1) AR003413A1 (de)
AT (1) ATE242631T1 (de)
CA (1) CA2214420A1 (de)
CY (1) CY2388B1 (de)
DE (1) DE69628672T2 (de)
DK (1) DK0879051T3 (de)
ES (1) ES2201176T3 (de)
HK (1) HK1015681A1 (de)
HR (1) HRP960154A2 (de)
IL (1) IL117809A (de)
PT (1) PT879051E (de)
TW (1) TW592729B (de)
WO (1) WO1996031201A1 (de)
ZA (1) ZA962752B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
ATE413166T1 (de) * 2004-11-22 2008-11-15 Hisamitsu Pharmaceutical Co Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff
EP1857103B1 (de) * 2005-02-28 2018-10-24 Hisamitsu Pharmaceutical Co., Inc. Transdermal absorbierbare präparation
WO2007035942A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal risperidone delivery system
JP5001271B2 (ja) 2006-06-09 2012-08-15 大日本住友製薬株式会社 新規テープ製剤
DE102007006244B4 (de) 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
WO2009086137A1 (en) * 2007-12-21 2009-07-09 Zars Pharma, Inc. Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs
US20120052112A1 (en) * 2009-02-24 2012-03-01 Hisamitsu Pharmaceutical Co., Inc. Risperidone-containing transdermal preparation and adhesive patch using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
WO1991002527A1 (en) * 1989-08-21 1991-03-07 Beth Israel Hospital Association Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists

Also Published As

Publication number Publication date
IL117809A0 (en) 1996-08-04
ZA962752B (en) 1997-10-06
IL117809A (en) 2000-10-31
EP0879051B9 (de) 2004-03-03
TW592729B (en) 2004-06-21
CA2214420A1 (en) 1996-10-10
CY2388B1 (en) 2004-09-10
HK1015681A1 (en) 1999-10-22
KR100437672B1 (ko) 2004-09-10
ES2201176T3 (es) 2004-03-16
JPH11503138A (ja) 1999-03-23
AR003413A1 (es) 1998-08-05
EP0879051B1 (de) 2003-06-11
DE69628672T2 (de) 2004-04-29
WO1996031201A1 (en) 1996-10-10
DK0879051T3 (da) 2003-09-29
ATE242631T1 (de) 2003-06-15
HRP960154A2 (en) 1997-08-31
AU5149296A (en) 1996-10-23
PT879051E (pt) 2003-10-31
AU696789B2 (en) 1998-09-17
EP0879051A1 (de) 1998-11-25

Similar Documents

Publication Publication Date Title
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
DE69530004D1 (de) Transdermale verabreichung von apomorphin
DE69634998D1 (de) Kontrolle von Kanten
DK42093D0 (da) Administrationsmetode
DE69624591T2 (de) Leitweglenkung von paketen
DE69633333D1 (de) Diphosphonatderivate von therapeutischen substanzen
DE69630328D1 (de) Präziser kontrollierter Niederschlag von Sauerstoff in Silizium
FR2736837B1 (fr) Dispositif pour l'administration, par electrotransport transdermique, de fentanyl ou de sufentanil
FI925727A (fi) Transdermal dosering av burprenorfin
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
DE69622780D1 (de) Transdermales therapeutisches System mit kontrollierter Wirkstofffreisetzung
DE69616259T2 (de) Gangschaltvorrichtung
NO973471D0 (no) Transdermal formulering
BR9607722A (pt) Formulação transdérmica
DE69628672D1 (de) Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit
DE69606165D1 (de) Bizyclische isothioharnstoff-derivate mit therapeutischer wirkung
DE59601488D1 (de) Drehzahlregeleinrichtung
DE69325073T2 (de) Borazinderivate von Hydridopolysilazanpolymeren
DE69603508D1 (de) Solubilisierungsverfahren von bezotriazol mit thiadiazol
DE69602195D1 (de) Speerspitzenanker
BR8807551A (pt) Variador de velocidade
DE19681207T1 (de) Therapeutische Verfahren und Zubereitungen unter Verwendung von Rubidiumionen
ATE239673T1 (de) Kontrolle von bioverschmützungen mit n- alkylheterocyclischen verbindungen
NO980862L (no) Zwitterionformer av trovafloxacin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition